Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 34, 2023 - Issue 1
Submit an article Journal homepage
1,983
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Quality of life and patient-reported symptoms in a Phase 4, real-world study of tildrakizumab in patients with moderate-to-severe psoriasis: Week 28 interim analysis

Neal Bhatiaa Therapeutics Clinical Research, San Diego, CA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7448-7809View further author information
ORCID Icon,
Jayme Heimb West Michigan Dermatology, Grandville, MI, USAView further author information
,
Brad Schenkelc Sun Pharmaceutical Industries, Inc., Princeton, NJ, USAView further author information
&
J. Gabriel Vasquezb West Michigan Dermatology, Grandville, MI, USAView further author information
Article: 2200872 | Received 07 Feb 2023, Accepted 21 Mar 2023, Published online: 31 May 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.